EpiBone
PrivateLast Round
Convertible Debt
Nov 8, 2024
Total Funding Raised
$42.42M
Momentum Score
50 /100
Company Overview
EpiBone, Inc. is a privately-held, clinical-stage regenerative medicine company focused on skeletal reconstruction. Founded in 2013 and spun out of Columbia University, the company develops technology to grow personalized bone and cartilage grafts. The process involves using a patient's own stem cells, which are seeded onto a custom-designed, 3D-printed scaffold that matches the patient's specific defect. This is then cultivated in a proprietary bioreactor to grow a living piece of bone or cartilage. The company is developing a pipeline of products, with its craniomaxillofacial bone product (EB-CMF) and a cartilage product having entered clinical trials. EpiBone has received funding from various investors and announced a relocation of its headquarters from Brooklyn, NY, to Jersey City, NJ, in 2023.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, 3D Printing, Biotech Equipment
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiBone Comps
Public and private peers based on sector, stage, and business model.
EpiBone Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Nov 8, 2024 | ||||
| Grant | Aug 16, 2024 | ||||
| Series B | Sep 20, 2023 | ||||
| Series B | Dec 21, 2022 | ||||
| Series B Extension | Nov 24, 2021 | ||||
Debt | Feb 10, 2021 |
EpiBone Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kendall Capital Partners | Convertible Debt |
| Plum Alley Investments | Series A |
| Tech Council Ventures | Series A |
| Hackensack Meridian Health | Series B |
| EMV Capital | Convertible Debt, Series B Extension, Seed |
| LifeSpan Vision Ventures | Convertible Debt |
| Breakout Labs | Series A, Grant, Seed |
EpiBone Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EpiBone's valuation, stock price, and market status.
